Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Snapshot

Immunopathogenesis of liver fibrosis in steatotic liver disease

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 987 Download: 48

Correspondence

Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances

Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

Clin Mol Hepatol. 2024;30(2):279-280. Published online March 20, 2024

DOI: https://doi.org/10.3350/cmh.2024.0191

View: 950 Download: 32 Crossref: 1

Original Article

JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis

Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang, Xiu-Ping Liu, Jian Wu

Clin Mol Hepatol. 2024;30(2):206-224. Published online January 8, 2024

DOI: https://doi.org/10.3350/cmh.2023.0506

View: 1740 Download: 132 Crossref: 2

Editorial

JCAD, a new potential therapeutic target in cholestatic liver disease

Byoung Kuk Jang

Clin Mol Hepatol. 2024;30(2):166-167. Published online March 8, 2024

DOI: https://doi.org/10.3350/cmh.2024.0128

View: 887 Download: 25 Crossref: 1

Snapshot

The role of the hepatic autonomic nervous system

Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin

Clin Mol Hepatol. 2023;29(4):1052-1055. Published online July 25, 2023

DOI: https://doi.org/10.3350/cmh.2023.0244

View: 1662 Download: 55

Review

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity

Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi

Clin Mol Hepatol. 2023;29(3):593-604. Published online February 13, 2023

DOI: https://doi.org/10.3350/cmh.2022.0391

View: 3553 Download: 309 Web of Science: 4 Crossref: 5

Original Article

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditions

Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun

Clin Mol Hepatol. 2023;29(2):465-481. Published online February 20, 2023

DOI: https://doi.org/10.3350/cmh.2022.0327

View: 4596 Download: 222 Web of Science: 3 Crossref: 6

Correspondence

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”

Yu Jun Wong, Sanchit Sharma, Giulia Tosetti, Xiaolong Qi, Massimo Primignani

Clin Mol Hepatol. 2023;29(1):188-190. Published online November 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0408

View: 2870 Download: 60 Web of Science: 2 Crossref: 2

Review

Management of refractory ascites

Florence Wong

Clin Mol Hepatol. 2023;29(1):16-32. Published online June 9, 2022

DOI: https://doi.org/10.3350/cmh.2022.0104

View: 9017 Download: 812 Web of Science: 10 Crossref: 11

Original Article

Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways

Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim

Clin Mol Hepatol. 2022;28(4):827-840. Published online June 22, 2022

DOI: https://doi.org/10.3350/cmh.2022.0068

View: 6403 Download: 347 Web of Science: 15 Crossref: 17

Review

The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls

Hae Lim Lee, Sung Won Lee

Clin Mol Hepatol. 2022;28(2):121-134. Published online September 27, 2021

DOI: https://doi.org/10.3350/cmh.2021.0239

View: 6053 Download: 360 Web of Science: 17 Crossref: 15

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Naoshi Odagiri, Tsutomu Matsubara, Misako Sato-Matsubara, Hideki Fujii, Masaru Enomoto, Norifumi Kawada

Clin Mol Hepatol. 2021;27(3):413-424. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0187

View: 13640 Download: 465 Web of Science: 25 Crossref: 24

Original Article

Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B

Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim

Clin Mol Hepatol. 2021;27(2):295-304. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0216

View: 5220 Download: 205 Web of Science: 16 Crossref: 19

Review

Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis

Le Thi Thanh Thuy, Hoang Hai, Norifumi Kawada

Clin Mol Hepatol. 2020;26(3):280-293. Published online June 4, 2020

DOI: https://doi.org/10.3350/cmh.2020.0037

View: 7319 Download: 230 Web of Science: 11 Crossref: 12

Guideline

KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications

Clin Mol Hepatol. 2020;26(2):83-127. Published online January 10, 2020

DOI: https://doi.org/10.3350/cmh.2019.0010n

View: 20805 Download: 1,332 Web of Science: 68 Crossref: 64

Review

Sarcopenia: Ammonia metabolism and hepatic encephalopathy

Ankur Jindal, Rakesh Kumar Jagdish

Clin Mol Hepatol. 2019;25(3):270-279. Published online April 22, 2019

DOI: https://doi.org/10.3350/cmh.2019.0015

View: 16204 Download: 907 Web of Science: 59 Crossref: 64

Case Report

Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report

Ju Hyun Lee, Chang Jin Yoon, Young Hoon Kim, Ho-Seong Han, Jai Young Cho, Haeryoung Kim, Eun Sun Jang, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2018;24(2):163-168. Published online July 19, 2017

DOI: https://doi.org/10.3350/cmh.2017.0002

View: 17004 Download: 227 Web of Science: 14 Crossref: 14

Review

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 15382 Download: 537 Web of Science: 84 Crossref: 81

Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Do Young Kim

Clin Mol Hepatol. 2017;23(2):123-124. Published online June 23, 2017

DOI: https://doi.org/10.3350/cmh.2017.0107

View: 6774 Download: 118

Case Report

Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures

Hyun-Jin Son, Dong Wook Kang, Joo Heon Kim, Hyun Young Han, Min Koo Lee

Clin Mol Hepatol. 2017;23(1):80-86. Published online March 14, 2017

DOI: https://doi.org/10.3350/cmh.2016.0034

View: 9666 Download: 192 Web of Science: 18 Crossref: 21

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 8774 Download: 134 Web of Science: 9 Crossref: 9

Liver Pathology

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma

Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(3):400-405. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0105

View: 11735 Download: 310 Web of Science: 13 Crossref: 12

Original Article

Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation

Ji Hye Jun, Jong Ho Choi, Si Hyun Bae, Seh Hoon Oh, Gi Jin Kim

Clin Mol Hepatol. 2016;22(3):372-381. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0032

View: 9913 Download: 152 Web of Science: 6 Crossref: 6

Liver Pathology

Undifferentiated embryonal sarcoma of the liver in an adult patient

Kyu Ho Lee, Mussin Nadiar Maratovich, Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(2):292-295. Published online June 25, 2016

DOI: https://doi.org/10.3350/cmh.2015.0102

View: 8362 Download: 147 Web of Science: 15 Crossref: 13

Original Article

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee

Clin Mol Hepatol. 2016;22(1):160-167. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.160

View: 11188 Download: 196 Web of Science: 79 Crossref: 69

Review

Nitric oxide in liver fibrosis: The role of inducible nitric oxide synthase

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 12188 Download: 227 Web of Science: 69 Crossref: 74

Original Article

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

Yoon Ok Jang, Baek Gyu Jun, Soon Koo Baik, Moon Young Kim, Sang Ok Kwon

Clin Mol Hepatol. 2015;21(2):141-149. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.141

View: 9088 Download: 131 Web of Science: 43 Crossref: 40

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B

In Ku Yo, Oh Sang Kwon, Jin Woong Park, Jong Joon Lee, Jung Hyun Lee, In Sik Won, Sun Young Na, Pil Kyu Jang, Pyung Hwa Park, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim

Clin Mol Hepatol. 2015;21(1):32-40. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.32

View: 9294 Download: 88 Web of Science: 13 Crossref: 12

Case Report

A case of focal nodular hyperplasia with growth progression during pregnancy

Min Ji Kim, Sang Young Han, Yang Hyun Baek, Sung Wook Lee, Hee Jin Kwon

Clin Mol Hepatol. 2014;20(4):392-397. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.392

View: 9404 Download: 67 Web of Science: 9 Crossref: 7

Original Article

Effects of candesartan and propranolol combination therapy versus propranolol monotherapy in reducing portal hypertension

Jae Hyun Kim, Jung Min Kim, Youn Zoo Cho, Ji Hoon Na, Hyun Sik Kim, Hyoun A Kim, Hye Won Kang, Soon Koo Baik, Sang Ok Kwon, Seung Hwan Cha, Young Ju Kim, Moon Young Kim

Clin Mol Hepatol. 2014;20(4):376-383. Published online December 24, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.4.376

View: 8684 Download: 80 Web of Science: 17 Crossref: 17

1 | 2 | 3 | 4 |

Viewed By 5403	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5370	MAFLD: How is it different from NAFLD?
Viewed By 5256	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3932	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3909	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search